Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Sponsor trial record
Sponsor · clinical trials

Biobizkaia Health Research Institute clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our Spain, Belgium, Italy and Switzerland registers with Biobizkaia Health Research Institute as lead sponsor. Synced 16 Nov 2026
6Current trials
3Recruiting now
2Drugs in these trials
4Trial registers
At a glance

Biobizkaia Health Research Institute is the lead sponsor of 6 current clinical trials in our Spain, Belgium, Italy and Switzerland registers. 3 are recruiting patients now. The most common phase is Observational. The drugs named most often in its trials are Faricimab and Vabysmo. The most-studied condition is Cancer.

ClinicalTrials.gov trials by status

  • Recruiting350%
  • Not yet open350%

Trials by phase

  • Observational350%
  • Phase 3117%
  • Not applicable117%
  • Phase 4117%
01

Clinical trials sponsored by Biobizkaia Health Research Institute

6 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Clinical Trial to Evaluate the Efficacy and Safety of Platelet-rich Plasma Infiltration in Chronic Omalgia
NCT07448285 · ClinicalTrials.gov ↗ · Chronic Pain
Phase 3 Recruiting 2026-02 Spain
Reduction of the Incidence of NAV in Neonatal Units (INBERNAV-Neo)
NCT07240038 · ClinicalTrials.gov ↗ · Pneumonia Ventilator Associated, Pneumonia Neonatal, Healthcare-associated Infections
Observational Recruiting 2024-04 Spain
Efficacy of Faricimab in Patients With Subretinal Hyper-reflective Material
NCT07403825 · ClinicalTrials.gov ↗ · Macular Degeneration, Age Related
Phase 4 Recruiting 2026-05 Spain
Understanding Lung Cancer Related Risk Factors and Their Impact
NCT06473870 · ClinicalTrials.gov ↗ · Lung Cancer Screening
Observational Not yet open 2024-07 Spain, Belgium
SUNRISE Aims to Create a Comprehensive, Engaging, and Sustainable Digital Health Promotion Program That Not Only Addresses Immediate Health Behaviours But Also Instils Lifelong Healthy Habits Among Adolescents. It is a Unique, Digitally Enhanced Program Combining Different Digital Solutions With New
NCT06931847 · Cancer
Observational Not yet open 2025-09 Spain, Italy, Belgium, Switzerland
The SUNRISE Project is Dedicated to Enhancing Primary Cancer Prevention Among Adolescents in Europe by Leveraging Innovative Digital Tools and Methodologies. SmartCoach, Developed by Swiss Research Institute for Public Health and Addiction (ISGF), is a Mobile Phone-based Life-skills Training Program
NCT06922201 · ClinicalTrials.gov ↗ · Cancer
Not applicable Not yet open 2025-09 Spain, Italy, Belgium, Switzerland

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Drugs in Biobizkaia Health Research Institute trials

2 compounds

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

03

Conditions in Biobizkaia Health Research Institute trials

7 conditions
Cancer2Lung Cancer Screening1Chronic Pain1Pneumonia Ventilator Associated1Pneumonia Neonatal1Healthcare-associated Infections1Macular Degeneration, Age Related1
06

Questions about Biobizkaia Health Research Institute trials

How many clinical trials does Biobizkaia Health Research Institute sponsor?

Biobizkaia Health Research Institute is the lead sponsor of 6 current trials on ClinicalTrials.gov in our Spain, Belgium, Italy and Switzerland registers, as of the registry sync on 16 November 2026. Completed and withdrawn studies are not counted.

Are Biobizkaia Health Research Institute trials recruiting?

Yes. 3 of its 6 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is Biobizkaia Health Research Institute testing?

Its current trials name 2 drugs and biologicals as interventions. The most frequent are Faricimab (1) and Vabysmo (1). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 16 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.